The activity of the CCL22/CKLF–CCR4 axis is likely centered in the bone marrow, associated with interactions between non-leukemic stromal cells and AML cells, resulting in increased production of CCL17 and other chemokines such as CCL5 and CXCL10 [92]. This evidence concerns the gene CCL22 and acute myeloid leukemia.